CosMED Pharmaceutical

CosMED Pharmaceutical is a Japanese biotechnology company specializing in the development and manufacture of transdermal drug delivery systems, particularly innovative microneedle technology. Founded as a venture from Kyoto Pharmaceutical University, the company has successfully commercialized the world's first hyaluronic acid microneedle patch for cosmetic use. Beyond cosmetics, CosMED is advancing a medical pipeline that includes microneedle-based delivery for vaccines, insulin, and other therapeutic agents to provide painless and efficient alternatives to injections. The company operates as both a product developer and a contract development and manufacturing organization (CDMO) for global partners.